• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

与种系突变相关的恶性布伦纳瘤

Malignant Brenner tumor associated with a germline mutation.

作者信息

Toboni Michael D, Smith Haller J, Dilley Sarah E, Novak Lea, Leath Charles A

机构信息

University of Alabama at Birmingham, Department of Obstetrics & Gynecology, United States.

University of Alabama at Birmingham, Division of Gynecologic Oncology, United States.

出版信息

Gynecol Oncol Rep. 2017 May 31;21:17-19. doi: 10.1016/j.gore.2017.05.006. eCollection 2017 Aug.

DOI:10.1016/j.gore.2017.05.006
PMID:28616458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5458647/
Abstract

•The first woman with a Malignant Brenner tumor and a mutation is described.•Not all women with epithelial ovarian cancers are referred for genetic counseling.•Women should be referred for genetics regardless of how rare the histology.

摘要

•描述了首例患有恶性布伦纳瘤且存在一种突变的女性。

•并非所有上皮性卵巢癌女性都会被转诊进行遗传咨询。

•无论组织学类型多么罕见，女性都应被转诊进行遗传学评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/adc9013932e5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/29938c763610/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/5be3d4543648/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/adc9013932e5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/29938c763610/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/5be3d4543648/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f3/5458647/adc9013932e5/gr3.jpg

相似文献

1
Malignant Brenner tumor associated with a germline mutation.与种系突变相关的恶性布伦纳瘤
Gynecol Oncol Rep. 2017 May 31;21:17-19. doi: 10.1016/j.gore.2017.05.006. eCollection 2017 Aug.
2
Uptake of testing for germline mutations in patients with non-mucinous epithelial ovarian cancers in Western Australia: a comparison of different genetic counseling methods.西澳大利亚州非黏液性上皮性卵巢癌患者种系突变检测的应用：不同遗传咨询方法的比较。
Int J Gynecol Cancer. 2019 Jul;29(6):1038-1042. doi: 10.1136/ijgc-2019-000389. Epub 2019 May 17.
3
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.基于组织学的转诊策略在卵巢癌中胚系 BRCA1 和 BRCA2 突变的应用。
Obstet Gynecol. 2012 Aug;120(2 Pt 1):235-40. doi: 10.1097/AOG.0b013e31825f3576.
4
A rare malignant Brenner tumor of the ovary in a 77-year-old woman: a case report.一名77岁女性的罕见卵巢恶性布伦纳瘤：病例报告
J Reprod Med. 2009 Aug;54(8):517-9.
5
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.BRCA1和BRCA2基因突变在卵巢癌病例中占很大比例。
Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536.
6
A Rare Case of Ruptured Malignant Ovarian Brenner Tumor.一例罕见的破裂性卵巢恶性勃勒纳瘤。
Am J Case Rep. 2023 Feb 13;24:e938680. doi: 10.12659/AJCR.938680.
7
Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.临床遗传学参与妇科肿瘤多学科讨论对遗传咨询转诊及BRCA突变检测的影响
Int J Gynecol Cancer. 2016 Jun;26(5):892-7. doi: 10.1097/IGC.0000000000000689.
8
Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.卵巢恶性 Brenner 肿瘤中复发性尿路上皮癌样 FGFR3 基因组改变。
Mod Pathol. 2021 May;34(5):983-993. doi: 10.1038/s41379-020-00699-1. Epub 2020 Oct 19.
9
Clinical and morphological features of the ovarian brenner tumour: current state of the problem.卵巢布伦纳瘤的临床和形态学特征：问题现状
Wiad Lek. 2020;73(7):1420-1426.
10
Identification of germline genetic mutations in patients with pancreatic cancer.胰腺癌患者种系基因突变的鉴定。
Cancer. 2015 Dec 15;121(24):4382-8. doi: 10.1002/cncr.29664. Epub 2015 Oct 6.

引用本文的文献

1
A report of twenty cases of ovarian Brenner tumor and literature review: a case series study.二十例卵巢 Brenner 肿瘤报告及文献复习：病例系列研究。
BMC Womens Health. 2024 Aug 27;24(1):471. doi: 10.1186/s12905-024-03316-4.
2
Malignant Brenner Tumor of the Ovary: A Systematic Review of the Literature.卵巢恶性勃勒纳瘤：文献系统综述
Cancers (Basel). 2024 Mar 9;16(6):1106. doi: 10.3390/cancers16061106.
3
Brenner Tumor of the Ovary: A 10-Year Single Institution Experience and Comprehensive Review of the Literature.卵巢 Brenner 肿瘤：10 年单机构经验及文献全面复习。

本文引用的文献

1
Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement.卵巢癌的种系和体细胞检测：SGO 临床实践声明。
Gynecol Oncol. 2024 Feb;181:170-178. doi: 10.1016/j.ygyno.2023.12.010. Epub 2024 Jan 12.
2
Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.对基因咨询后患者不进行BRCA基因检测原因的大型前瞻性分析。
J Genet Couns. 2017 Aug;26(4):859-865. doi: 10.1007/s10897-016-0064-5. Epub 2017 Jan 16.
3
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Med Sci (Basel). 2023 Feb 7;11(1):18. doi: 10.3390/medsci11010018.
遗传/家族性高风险评估：乳腺和卵巢，第 2.2015 版。
J Natl Compr Canc Netw. 2016 Feb;14(2):153-62. doi: 10.6004/jnccn.2016.0018.
4
Nonserous Ovarian Epithelial Tumors.非浆液性卵巢上皮性肿瘤
Surg Pathol Clin. 2011 Mar;4(1):397-459. doi: 10.1016/j.path.2010.12.012. Epub 2011 Feb 22.
5
Inherited Mutations in Women With Ovarian Carcinoma.遗传性突变与卵巢癌女性。
JAMA Oncol. 2016 Apr;2(4):482-90. doi: 10.1001/jamaoncol.2015.5495.
6
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.BRCA1/2 种系检测在卵巢癌中的应用：现状与新方向的机遇。
Gynecol Oncol. 2016 Jan;140(1):90-4. doi: 10.1016/j.ygyno.2015.10.010. Epub 2015 Oct 22.
7
Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.遵循美国国立综合癌症网络（NCCN）关于转诊至癌症遗传专业人员的指南的模式。
Gynecol Oncol. 2015 Jul;138(1):109-14. doi: 10.1016/j.ygyno.2015.04.029. Epub 2015 Apr 28.
8
Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.卵巢 Brenner 肿瘤：形态学和免疫组织化学分析提示来源于输卵管上皮。
Eur J Cancer. 2013 Dec;49(18):3839-49. doi: 10.1016/j.ejca.2013.08.011. Epub 2013 Sep 5.
9
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.他莫昔芬和 BRCA1/2 基因突变携带者对侧乳腺癌风险。
J Clin Oncol. 2013 Sep 1;31(25):3091-9. doi: 10.1200/JCO.2012.47.8313. Epub 2013 Aug 5.
10
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.胚系 BRCA 突变与前列腺癌中淋巴结受累、远处转移和不良生存结局的风险增加相关。
J Clin Oncol. 2013 May 10;31(14):1748-57. doi: 10.1200/JCO.2012.43.1882. Epub 2013 Apr 8.